357 related articles for article (PubMed ID: 21146531)
1. Dissecting DNA hypermethylation in cancer.
Estécio MR; Issa JP
FEBS Lett; 2011 Jul; 585(13):2078-86. PubMed ID: 21146531
[TBL] [Abstract][Full Text] [Related]
2. Genomic insights into cancer-associated aberrant CpG island hypermethylation.
Sproul D; Meehan RR
Brief Funct Genomics; 2013 May; 12(3):174-90. PubMed ID: 23341493
[TBL] [Abstract][Full Text] [Related]
3. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
4. Navigating the DNA methylation landscape of cancer.
Nishiyama A; Nakanishi M
Trends Genet; 2021 Nov; 37(11):1012-1027. PubMed ID: 34120771
[TBL] [Abstract][Full Text] [Related]
5. [DNA methylation and cancer].
Yoshikawa H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer.
Fain JS; Loriot A; Diacofotaki A; Van Tongelen A; De Smet C
Sci Rep; 2021 Aug; 11(1):17346. PubMed ID: 34462486
[TBL] [Abstract][Full Text] [Related]
7. The rise and fall of genomic methylation in cancer.
El-Osta A
Leukemia; 2004 Feb; 18(2):233-7. PubMed ID: 14628069
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and cancer.
Kulis M; Esteller M
Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
[TBL] [Abstract][Full Text] [Related]
10. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
[TBL] [Abstract][Full Text] [Related]
11. DNA hypermethylation in tumorigenesis: epigenetics joins genetics.
Baylin SB; Herman JG
Trends Genet; 2000 Apr; 16(4):168-74. PubMed ID: 10729832
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation, cancer susceptibility, and nutrient interactions.
Davis CD; Uthus EO
Exp Biol Med (Maywood); 2004 Nov; 229(10):988-95. PubMed ID: 15522834
[TBL] [Abstract][Full Text] [Related]
13. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
14. Changes in correlation between promoter methylation and gene expression in cancer.
Moarii M; Boeva V; Vert JP; Reyal F
BMC Genomics; 2015 Oct; 16():873. PubMed ID: 26510534
[TBL] [Abstract][Full Text] [Related]
15. Alterations of DNA methylation and clinicopathological diversity of human cancers.
Kanai Y
Pathol Int; 2008 Sep; 58(9):544-58. PubMed ID: 18801069
[TBL] [Abstract][Full Text] [Related]
16. DNMT cooperativity--the developing links between methylation, chromatin structure and cancer.
El-Osta A
Bioessays; 2003 Nov; 25(11):1071-84. PubMed ID: 14579248
[TBL] [Abstract][Full Text] [Related]
17. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M; Herman JG
J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond.
Huang W; Li H; Yu Q; Xiao W; Wang DO
J Exp Clin Cancer Res; 2022 Mar; 41(1):100. PubMed ID: 35292092
[TBL] [Abstract][Full Text] [Related]
19. [DNA methylation. From basic research to routine diagnostics].
Lehmann U
Pathologe; 2010 Oct; 31 Suppl 2():274-9. PubMed ID: 20824434
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors.
Saghafinia S; Mina M; Riggi N; Hanahan D; Ciriello G
Cell Rep; 2018 Oct; 25(4):1066-1080.e8. PubMed ID: 30355485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
